nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Abnormal faeces—Hydrochlorothiazide—nephrolithiasis	0.0574	0.0574	CcSEcCtD
Tolcapone—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.0432	0.0432	CcSEcCtD
Tolcapone—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0312	0.0312	CcSEcCtD
Tolcapone—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0256	0.0256	CcSEcCtD
Tolcapone—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0185	CcSEcCtD
Tolcapone—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0183	0.0183	CcSEcCtD
Tolcapone—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0177	CcSEcCtD
Tolcapone—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0174	0.0174	CcSEcCtD
Tolcapone—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.015	0.015	CcSEcCtD
Tolcapone—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0148	CcSEcCtD
Tolcapone—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0146	0.0146	CcSEcCtD
Tolcapone—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0138	CcSEcCtD
Tolcapone—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0137	CcSEcCtD
Tolcapone—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0136	CcSEcCtD
Tolcapone—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0134	CcSEcCtD
Tolcapone—Injury—Hydrochlorothiazide—nephrolithiasis	0.013	0.013	CcSEcCtD
Tolcapone—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0128	CcSEcCtD
Tolcapone—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0126	CcSEcCtD
Tolcapone—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0125	CcSEcCtD
Tolcapone—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0123	CcSEcCtD
Tolcapone—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Tolcapone—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0118	CcSEcCtD
Tolcapone—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0117	CcSEcCtD
Tolcapone—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0117	CcSEcCtD
Tolcapone—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Tolcapone—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0113	CcSEcCtD
Tolcapone—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0107	CcSEcCtD
Tolcapone—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Tolcapone—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Tolcapone—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Tolcapone—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.01	0.01	CcSEcCtD
Tolcapone—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00963	0.00963	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00957	0.00957	CcSEcCtD
Tolcapone—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00951	0.00951	CcSEcCtD
Tolcapone—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00948	0.00948	CcSEcCtD
Tolcapone—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00923	0.00923	CcSEcCtD
Tolcapone—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00905	0.00905	CcSEcCtD
Tolcapone—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.009	0.009	CcSEcCtD
Tolcapone—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.009	0.009	CcSEcCtD
Tolcapone—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00892	0.00892	CcSEcCtD
Tolcapone—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0088	0.0088	CcSEcCtD
Tolcapone—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00875	0.00875	CcSEcCtD
Tolcapone—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00866	0.00866	CcSEcCtD
Tolcapone—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00861	0.00861	CcSEcCtD
Tolcapone—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00839	0.00839	CcSEcCtD
Tolcapone—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00826	0.00826	CcSEcCtD
Tolcapone—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0082	0.0082	CcSEcCtD
Tolcapone—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00818	0.00818	CcSEcCtD
Tolcapone—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00812	0.00812	CcSEcCtD
Tolcapone—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00779	0.00779	CcSEcCtD
Tolcapone—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00768	0.00768	CcSEcCtD
Tolcapone—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00736	0.00736	CcSEcCtD
Tolcapone—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00728	0.00728	CcSEcCtD
Tolcapone—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00707	0.00707	CcSEcCtD
Tolcapone—Tension—Hydrochlorothiazide—nephrolithiasis	0.00704	0.00704	CcSEcCtD
Tolcapone—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00703	0.00703	CcSEcCtD
Tolcapone—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00697	0.00697	CcSEcCtD
Tolcapone—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0069	0.0069	CcSEcCtD
Tolcapone—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00676	0.00676	CcSEcCtD
Tolcapone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00672	0.00672	CcSEcCtD
Tolcapone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00666	0.00666	CcSEcCtD
Tolcapone—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00663	0.00663	CcSEcCtD
Tolcapone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00659	0.00659	CcSEcCtD
Tolcapone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00647	0.00647	CcSEcCtD
Tolcapone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00645	0.00645	CcSEcCtD
Tolcapone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00643	0.00643	CcSEcCtD
Tolcapone—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00634	0.00634	CcSEcCtD
Tolcapone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00631	0.00631	CcSEcCtD
Tolcapone—Cough—Hydrochlorothiazide—nephrolithiasis	0.00626	0.00626	CcSEcCtD
Tolcapone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00611	0.00611	CcSEcCtD
Tolcapone—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00611	0.00611	CcSEcCtD
Tolcapone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00611	0.00611	CcSEcCtD
Tolcapone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00609	0.00609	CcSEcCtD
Tolcapone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00604	0.00604	CcSEcCtD
Tolcapone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00597	0.00597	CcSEcCtD
Tolcapone—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0059	0.0059	CcSEcCtD
Tolcapone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00586	0.00586	CcSEcCtD
Tolcapone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00576	0.00576	CcSEcCtD
Tolcapone—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00573	CcSEcCtD
Tolcapone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00571	0.00571	CcSEcCtD
Tolcapone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00566	0.00566	CcSEcCtD
Tolcapone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00558	0.00558	CcSEcCtD
Tolcapone—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00547	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00533	CcSEcCtD
Tolcapone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00526	0.00526	CcSEcCtD
Tolcapone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00522	CcSEcCtD
Tolcapone—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00521	CcSEcCtD
Tolcapone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00515	0.00515	CcSEcCtD
Tolcapone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00509	0.00509	CcSEcCtD
Tolcapone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00505	CcSEcCtD
Tolcapone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00501	0.00501	CcSEcCtD
Tolcapone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00501	0.00501	CcSEcCtD
Tolcapone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00483	0.00483	CcSEcCtD
Tolcapone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00479	0.00479	CcSEcCtD
Tolcapone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00465	0.00465	CcSEcCtD
Tolcapone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00463	CcSEcCtD
Tolcapone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00463	CcSEcCtD
Tolcapone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00431	CcSEcCtD
Tolcapone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0042	0.0042	CcSEcCtD
Tolcapone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00414	CcSEcCtD
Tolcapone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00401	0.00401	CcSEcCtD
Tolcapone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00387	0.00387	CcSEcCtD
Tolcapone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00372	0.00372	CcSEcCtD
Tolcapone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00369	0.00369	CcSEcCtD
Tolcapone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00369	0.00369	CcSEcCtD
Tolcapone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00367	0.00367	CcSEcCtD
Tolcapone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00348	0.00348	CcSEcCtD
